337 related articles for article (PubMed ID: 26268684)
1. Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disorders.
Dimitropoulos K; Karatzas A; Papandreou C; Daliani D; Zachos I; Pisters LL; Tzortzis V
Andrologia; 2016 May; 48(4):425-30. PubMed ID: 26268684
[TBL] [Abstract][Full Text] [Related]
2. Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group.
Gerdtsson A; Håkansson U; Törnblom M; Jancke G; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
Eur Urol Oncol; 2020 Jun; 3(3):382-389. PubMed ID: 31506250
[TBL] [Abstract][Full Text] [Related]
3. Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection.
Jacobsen KD; Ous S; Waehre H; Trasti H; Stenwig AE; Lien HH; Aass N; Fosså SD
Br J Cancer; 1999 Apr; 80(1-2):249-55. PubMed ID: 10390004
[TBL] [Abstract][Full Text] [Related]
4. Nerve-sparing retroperitoneal lymph node dissection for advanced testicular cancer after chemotherapy.
Nonomura N; Nishimura K; Takaha N; Inoue H; Nomoto T; Mizutani Y; Nakao M; Okuyama A; Miki T
Int J Urol; 2002 Oct; 9(10):539-44. PubMed ID: 12445231
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive evaluation of sexual and reproductive outcomes following robot-assisted retroperitoneal lymph node dissection for nonseminomatous germ cell tumor.
Mistretta FA; de Cobelli O; Verze P; Botticelli F; Jannello L; Luzzago S; Cozzi G; Bianchi R; Di Trapani E; Ferro M; Cordima G; Bottero D; Matei DV; Mirone V; Musi G
Asian J Androl; 2022; 24(6):579-583. PubMed ID: 35381697
[TBL] [Abstract][Full Text] [Related]
6. Post-chemotherapy nerve-sparing retroperitoneal lymph node dissection for advanced germ cell tumor.
Miki T; Mizutani Y; Nakamura T; Kawauchi A; Nagahara A; Nonomura N; Okuyama A
Int J Urol; 2009 Apr; 16(4):379-82. PubMed ID: 19191930
[TBL] [Abstract][Full Text] [Related]
7. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
[TBL] [Abstract][Full Text] [Related]
8. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
9. Andrological complications following retroperitoneal lymph node dissection for testicular cancer.
Crestani A; Esperto F; Rossanese M; Giannarini G; Nicolai N; Ficarra V
Minerva Urol Nefrol; 2017 Jun; 69(3):209-219. PubMed ID: 27879966
[TBL] [Abstract][Full Text] [Related]
10. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
[TBL] [Abstract][Full Text] [Related]
11. Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes.
Woldu SL; Moore JA; Ci B; Freifeld Y; Clinton TN; Aydin AM; Singla N; Laura-Maria K; Hutchinson RC; Amatruda JF; Sagalowsky A; Lotan Y; Arriaga Y; Margulis V; Xie Y; Bagrodia A
Eur Urol Oncol; 2018 Aug; 1(3):242-251. PubMed ID: 31058267
[TBL] [Abstract][Full Text] [Related]
12. Retroperitoneal lymph node dissection after chemotherapy.
Winter C; Raman JD; Sheinfeld J; Albers P
BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
[TBL] [Abstract][Full Text] [Related]
13. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
Coogan CL; Hejase MJ; Wahle GR; Foster RS; Rowland RG; Bihrle R; Donohue JP
J Urol; 1996 Nov; 156(5):1656-8. PubMed ID: 8863564
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S
J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of the management of post-chemotherapy retroperitoneal lymph node dissection-associated anejaculation.
Hsiao W; Deveci S; Mulhall JP
BJU Int; 2012 Oct; 110(8):1196-200. PubMed ID: 22233208
[TBL] [Abstract][Full Text] [Related]
16. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
[TBL] [Abstract][Full Text] [Related]
17. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
19. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.
Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S
Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of post-chemotherapy robot-assisted retroperitoneal lymph node dissection in testicular cancer: multi-institutional study.
Abdul-Muhsin H; Rocco N; Navaratnam A; Woods M; L'Esperance J; Castle E; Stroup S
World J Urol; 2021 Oct; 39(10):3833-3838. PubMed ID: 33959785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]